Male infertility is a common issue, affecting 40%–50% of infertile couples. Infections of the genitourinary tract contribute to 15% of cases, with various pathogens, including bacteria and viruses, entering through sexual contact or other routes. It is known that an abnormal genital Microbiome can affect male fertility. While some acute infections may result in inflammation causing epididymitis, orchitis, prostatitis, and urethritis, very often infections may be asymptomatic, making diagnosis and treatment more challenging.

At Fertilysis, we place emphasis on addressing the potential role of male factor in unexplained infertility. Through our specialized male-oriented testing panels, we gather essential information for a thorough understanding of male fertility, enhancing the overall chances of success for the couple.

Retesting is essential for evaluating the effectiveness of your treatment and making necessary adjustments. It allows us to determine if the treatment was effective or needs to be repeated, preventing recurring infections. Through careful reevaluation, we ensure that your personalized treatment plan remains effective. Additionally, it helps to identify any microbiome imbalances that may have arisen post-treatment. Consequently, it is recommended that the retesting occurs no later than 1 – 2 months following completion of treatment, and, in any case, it should take place no longer than 6 months from the initial test.